DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
151	ラスムッセン脳炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00545493 (ClinicalTrials.gov)	November 2002	16/10/2007	Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis	Efficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis With Start of Treatment in the Acute Disease Stage. Prospective, Randomised, Open Parallel Group Study	Rasmussen Encephalitis	Drug: Tacrolimus;Drug: i.v. immunoglobulins	University Hospital, Bonn	Octapharma;Astellas Pharma GmbH	Active, not recruiting	N/A	N/A	Both	16	Phase 2;Phase 3	Germany

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00545493
(ClinicalTrials.gov)

November 2002

16/10/2007

Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis

Efficacy of Tacrolimus and i.v.-Immunoglobulins in Rasmussen Encephalitis With Start of Treatment in the Acute Disease Stage. Prospective, Randomised, Open Parallel Group Study

Rasmussen Encephalitis

Drug: Tacrolimus;Drug: i.v. immunoglobulins

University Hospital, Bonn

Octapharma;Astellas Pharma GmbH

Active, not recruiting

N/A

Both

Phase 2;Phase 3

Germany